COVID-19 infection is growing in a rapid rate. Due to unavailability of specific drugs, early detection of (COVID-19) patients is essential for disease cure and control. There is a vital need to detect the disease at early stage and instantly quarantine the infected people. Many research have been going on, however, none of them introduces satisfactory results yet. In spite of its simplicity, K-Nearest Neighbor (KNN) classifier has proven high flexibility in complex classification problems. However, it can be easily trapped. In this paper, a new COVID-19 diagnose strategy is introduced, which is called COVID-19 Patients Detection Strategy (CPDS). The novelty of CPDS is concentrated in two contributions. The first is a new hybrid feature selection Methodology (HFSM), which elects the most informative features from those extracted from chest Computed Tomography (CT) images for COVID-19 patients and non COVID-19 peoples. HFSM is a hybrid methodology as it combines evidence from both wrapper and filter feature selection methods. It consists of two stages, namely; Fast Selection Stage (FS 2 ) and Accurate Selection Stage (AS 2 ). FS 2 relies on filter, while AS 2 uses Genetic Algorithm (GA) as a wrapper method. As a hybrid methodology, HFSM elects the significant features for the next detection phase. The second contribution is an enhanced K-Nearest Neighbor (EKNN) classifier, which avoids the trapping problem of the traditional KNN by adding solid heuristics in choosing the neighbors of the tested item. EKNN depends on measuring the degree of both closeness and strength of each neighbor of the tested item, then elects only the qualified neighbors for classification. Accordingly, EKNN can accurately detect infected patients with the minimum time penalty based on those significant features selected by HFSM technique. Extensive experiments have been done considering the proposed detection strategy as well as recent competitive techniques on the chest CT images. Experimental results have shown that the proposed detection strategy outperforms recent techniques as it introduces the maximum accuracy rate.

No abstract

No abstract

COVID-19, as an infectious disease, has shocked the world and still threatens the lives of billions of people. Early detection of COVID-19 patients is an important issue for treating and controlling the disease from spreading. In this paper, a new strategy for detecting COVID-19 infected patients will be introduced, which is called Distance Biased Naïve Bayes (DBNB). The novelty of DBNB as a proposed classification strategy is concentrated in two contributions. The first is a new feature selection technique called Advanced Particle Swarm Optimization (APSO) which elects the most informative and significant features for diagnosing COVID-19 patients. APSO is a hybrid method based on both filter and wrapper methods to provide accurate and significant features for the next classification phase. The considered features are extracted from Laboratory findings for different cases of people, some of whom are COVID-19 infected while some are not. APSO consists of two sequential feature selection stages, namely; Initial Selection Stage (IS 2 ) and Final Selection Stage (FS 2 ). IS 2 uses filter technique to quickly select the most important features for diagnosing COVID-19 patients while removing the redundant and ineffective ones. This behavior minimizes the computational cost in FS 2 , which is the next stage of APSO. FS 2 uses Binary Particle Swarm Optimization (BPSO) as a wrapper method for accurate feature selection. The second contribution of this paper is a new classification model, which combines evidence from statistical and distance based classification models. The proposed classification technique avoids the problems of the traditional NB and consists of two modules; Weighted Naïve Bayes Module (WNBM) and Distance Reinforcement Module (DRM). The proposed DBNB tries to accurately detect infected patients with the minimum time penalty based on the most effective features selected by APSO. DBNB has been compared with recent COVID-19 diagnose strategies. Experimental results have shown that DBNB outperforms recent COVID-19 diagnose strategies as it introduce the maximum accuracy with the minimum time penalty.

No abstract